Optics News

In a 12-month case study follow-up, a patient with widespread vision issues after a suspected concussion experienced significant improvement in all oculomotor metrics, according to research from Melissa Hunfalvay, PhD, AASP-CC, APA, AOA, USPTA1, co-founder and chief science officer of RightEye.

A memorandum of agreement has been signed to establish the first School of Optometry in Haiti, representing a collaboration between I’Universite d’Etat d’Haiti, Brien Holden Vision Institute, Optometry Giving Sight, VOSH International and Charity Vision, with support from University of Montreal.

Houghton Mifflin Harcourt will distribute King-Devick Technologies’ Reading Acceleration Program to students in grades 1 through 4 beginning with the 2017 school year.

“The visibility of a target object may be affected by the specific properties of the background scene at and near the target’s location and by how uncertain the observer is from one occasion to the next about the values of the background and target properties,” according to a study from Stephen Sebastian, PhD, and fellow researchers at the University of Texas.

WASHINGTON – A large study of children in China found that participation in more outdoor activities and having fewer myopic parents were both associated with a lower incidence of and less progressive myopia.

Individuals, agencies and organizations must take advantage of their positions to make a difference for the 21 million people in the U.S. with vision impairment, John E. Crews, DPA, accomplished researcher, author and vision disability advocate, said at the Focus on Eye Health National Summit.

Binocular games and movies that rebalance contrast are a promising option for treating amblyopia, according to research from Krista R. Kelly, PhD, and colleagues presented at the Association for Research in Vision and Ophthalmology.

Inspired by moth eyes, researchers have developed a new antireflection film to be used on mobile phones.

The incidence of myopia will grow to 50% of the world population, or 5 billion people, by 2050, and 10% will have high myopia if these trends continue, according to Serge Resnikoff, MD, PhD, during the Prevent Blindness Focus on Eye Health National Summit.

Low-dose atropine showed equal efficacy in slowing down myopia progression in children and had fewer side effects than higher doses in a large meta-analysis of published studies